Melissa Skrepak, TLMHC, IADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 7 Okoboji Grove Rd, Arnolds Park, IA 51331 Phone: 712-339-2422 |
News Archive
A new staging system developed with a more accessible test to predict the chance of survival in patients living with light chain (AL) amyloidosis.
Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announces the opening of a new physical therapy clinic in Silver Spring, MD.
A review of global fertility care, completed for World Infertility Month (June), has revealed that 94% of the 90 million patients around the world with fertility problems never receive any kind of care for their condition.
The Center for Medicare and Medicaid Services posted final Medicare payment rules Tuesday that include a cut in physician reimbursement rates.
Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) that is also in single-agent clinical trials, including a pivotal trial for relapsed and refractory Hodgkin lymphoma and a phase II trial for systemic anaplastic large cell lymphoma.
› Verified 3 days ago